Bulletin
Investor Alert

New York Markets Close in:

ResMed Inc.

NYS: RMD

GO
/marketstate/country/us

Market open

 --Real time quotes

Aug 19, 2022, 12:41 p.m.

RMD
/zigman2/quotes/204675483/composite

$

234.02

Change

-1.99 -0.84%

Volume

Volume 174,443

Real time quotes

/zigman2/quotes/204675483/composite

Previous close

$ 236.00

$ 234.02

Change

-1.99 -0.84%

Day low

Day high

$232.59

$236.00

Open

52 week low

52 week high

$189.40

$301.34

Open

Insider Actions for ResMed Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/22/2022 Brett A. Sandercock
Chief Financial Officer
7,500   Disposition at $235 per share. 1,762,500
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/22/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
07/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $224.94 per share. 1,276,534
07/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
07/05/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $212.33 per share. 328,049
06/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $202.54 per share. 1,149,414
06/15/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
06/03/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $209.44 per share. 323,584
05/16/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $196.61 per share. 1,115,761
05/16/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
05/03/2022 David Brian Pendarvis
Chief Administrative Officer
1,545   Disposition at $200 per share. 309,000
04/18/2022 Michael J. Farrell
Chief Executive Officer
5,675   Disposition at $232.41 per share. 1,318,926
04/18/2022 Robert Andrew Douglas
President and COO
8,000   Disposition at $233.29 per share. 1,866,320
04/18/2022 Michael J. Farrell
Chief Executive Officer
5,675   Derivative/Non-derivative trans. at $57.76 per share. 327,788
04/18/2022 Robert Andrew Douglas
President and COO
8,000   Derivative/Non-derivative trans. at $58.24 per share. 465,920
04/11/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Disposition at $247 per share. 617,500
04/11/2022 Brett A. Sandercock
Chief Financial Officer
2,500   Derivative/Non-derivative trans. at $57.76 per share. 144,400
04/04/2022 David Brian Pendarvis
Chief Administrative Officer
1,544   Disposition at $246.6 per share. 380,750

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
5 Purchases
5 Sales
18,850
21,940
Last 6 months
12 Purchases
15 Sales
56,875
64,598
Last 12 months
55 Purchases
64 Sales
373,731
357,576

Officers and Executives

Dr. Peter C. Farrell
Non-Executive Chairman
Mr. Michael J. Farrell
Chief Executive Officer & Director
Mr. Robert Andrew Douglas
President & Chief Operating Officer
Mr. Brett A. Sandercock
Chief Financial Officer
Ms. Urvashi Tyagi
Chief Technology Officer
Dr. Carlos M. Nunez
Chief Medical Officer
Mr. David Brian Pendarvis
Secretary & Chief Administrative Officer
Ms. Lucile Blaise
President-Sleep & Respiratory Care
Mr. Hemanth Reddy
Chief Strategy Officer
Mr. Bobby Ghoshal
President-SaaS
Ms. Amy Wakeham
Head-Investor Relations
Ms. Vered Keisar
Chief People Officer
Dr. John B Hernandez
Independent Director
Dr. Tan Desney
Independent Director
Mr. Richard Sulpizio
Independent Director
Mr. Ronald R. Taylor
Lead Independent Director
Ms. Carol J. Burt
Independent Director
Ms. Karen Ruth Drexler
Independent Director
Ms. Harjit Gill
Independent Director
Mr. Jan D. de Witte
Independent Director
Link to MarketWatch's Slice.